Cover Image
Market Research Report

Pharmaceutical Packaging 2017 to 2021

Published by Allied Development Corp. Product code 235030
Published Content info 400 Pages
Delivery time: 1-2 business days
Price
Back to Top
Pharmaceutical Packaging 2017 to 2021
Published: January 27, 2017 Content info: 400 Pages
Description

"Pharmaceutical Packaging to 2021" examines the global pharmaceutical packaging industry, which reached US$5.1 billion in primary packaging value in 2016. This comprehensive study examines industry technology, industry participants, and market trends in order to forecast the market through 2021.

This large packaging market will continue to grow due to:

  • the growing market of aged consumers
  • government regulations driving huge programs such as serialization
  • innovative packages for child resistance
  • new technology for packages that ensure patients adhere to their drug regimens
  • increasing demands from more sophisticated pharmaceuticals
  • increasing demands from new drug delivery systems

Quantitative forecasts include primary packaging, secondary packaging by geographic region, child-resistance, patient compliance, and many others.

Table of Contents
Product Code: RPP17A

Table of Contents

Section I: Introduction

  • A. Pharmaceuticals defined
  • B. Pharmaceutical packaging defined
  • C. Study organization
  • D. Methodology
  • E. Geographic regions
  • F. Conventions

Section II: Technology

  • A. Technology priorities 1
    • 1. Drug safety and efficacy
    • 2. Drug sensitivity
    • 3. Drug delivery method
    • 4. Regulations - drug safety and efficacy
    • 5. Packaging cost
    • 6. Environment and health
    • 7. Packaging requirements
  • B. Devices vs. packages definition
    • 1. Inhalers
    • 2. Pen injection systems
    • 3. Auto-injectors
    • 4. Wearable devices
    • C. Primary packaging
    • 1. Ampules
    • 2. Blister packs
    • 3. Bottles
    • 4. Canisters
    • 5. Cartridges
    • 6. Intravenous (IV) bags
    • 7. Mini-jars
    • 8. Pouches
    • 9. Pre-fillable syringes
    • 10. Tubes
    • 11. Vials
    • 12. Closures
    • 13. Innerseals
  • D. Secondary packaging
    • 1. Blister cards and wallets
    • 2. Folding cartons
    • 3. Trays
    • 4. Other
    • 5. Labels
    • 6. Shrink bands
  • E. Child-resistant packaging
    • 1. Multi-dose packaging
    • 2. Unit-dose packaging
    • 3. Additional child-resistant technologies
  • F. Compliance packaging
    • 1. Calender blister pack
    • 2. Dose indicators
    • 3. Electronic compliance monitoring (ECM)
    • 4. ECM closure
    • 5. ECM blister pack
    • 6. Wallet
    • 7. Summary
  • G. Tamper-evident packaging
    • 1. Inherently tamper-evident packages
    • 2. Not inherently tamper evident
    • 3. Pre-filled syringes
  • H. Unit-dose packaging
  • I. Anti-counterfeit packaging
    • 1. Existing solutions
    • 2. Serialization
  • J. Labeling
  • K. Identification and tracking
    • 1. Barcodes
    • 2. Radio frequency identification (RFID)
    • 3. Near field communications
  • L. Active packaging
  • M. Packaging processes for sterile drugs
    • 1. Traditional aseptic packaging
    • 2. Aseptic packaging with barrier isolation technology
    • 3. Terminal sterilization (in-package sterilization)
  • N. Packaging processes for non-sterile drugs
  • O. Pharmaceutical packaging materials
    • 1. Polymers
    • 2. Glass
    • 3. Aluminum foil
    • 4. Paper
    • 5. Paperboard
    • 6. Other
  • P. Pharmaceutical packaging structures
    • 1. Blister pack structures
    • 2. Bottles, vials, ampules, cartridges, and mini-jars
    • 3. Pouch structures
    • 4. Pre-filled syringes
    • 5. IV bags
    • 6. Tube structures
    • 7. Secondary packaging
    • 8. Other structures
  • Q. Pharmaceutical packaging equipment technology
    • 1. Filling equipment
    • 2. Filling equipment suppliers

Section III: Market Trends and Projections

  • A. Pharmaceutical industry drivers and trends
    • 1. Government policies6
    • 2. Macro environment
    • 3. New drugs
    • 4. New drug delivery techniques
    • 5. Biologics
    • 6. Generic drugs
    • 7. Delivery devices
    • 8. New drug production techniques
  • B. Pharmaceutical packaging industry drivers and trends
    • 1. Underlying product trends
    • 2. Regulatory environment
    • 3. Government healthcare programs
    • 4. Product differentiation
    • 5. Drug safety
    • 6. Conversions from prescription to OTC
    • 7. Alternative drug delivery methods
Back to Top